Compare DASH & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DASH | ELV |
|---|---|---|
| Founded | 2013 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0B | 76.6B |
| IPO Year | 2020 | N/A |
| Metric | DASH | ELV |
|---|---|---|
| Price | $207.02 | $367.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 33 | 18 |
| Target Price | $283.36 | ★ $392.06 |
| AVG Volume (30 Days) | ★ 3.7M | 1.2M |
| Earning Date | 02-18-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.91 | ★ 24.39 |
| Revenue | $12,635,000,000.00 | ★ $194,820,000,000.00 |
| Revenue This Year | $30.98 | $13.25 |
| Revenue Next Year | $30.31 | $3.31 |
| P/E Ratio | $107.52 | ★ $15.37 |
| Revenue Growth | ★ 24.46 | 11.96 |
| 52 Week Low | $155.40 | $273.71 |
| 52 Week High | $285.50 | $458.75 |
| Indicator | DASH | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 36.62 | 56.57 |
| Support Level | $208.11 | $365.61 |
| Resistance Level | $217.67 | $383.00 |
| Average True Range (ATR) | 7.70 | 9.06 |
| MACD | -2.51 | 0.29 |
| Stochastic Oscillator | 18.61 | 59.99 |
Founded in 2013 and headquartered in San Francisco, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food items on-demand for delivery or in-store from merchants. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish a presence online, market their offerings, and meet demand through delivery. The firm provides similar service to nonrestaurant businesses, such as grocery, retail, and pet supplies. Dash is also rolling out nascent technology like drone delivery in an effort to continually innovate and provide the best possible service to supply-side and demand-side contingents of its marketplace.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.